{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:01:09Z","timestamp":1787166069559,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xphs.2026.104169","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:41:19Z","timestamp":1768664479000},"page":"104169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Do we worry too much about polysorbate degradation? An industry-wide perspective with real-life case studies"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4583-0871","authenticated-orcid":false,"given":"Klaus","family":"Wuchner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1603-7951","authenticated-orcid":false,"given":"Felix","family":"Nikels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-9533","authenticated-orcid":false,"given":"Patrick","family":"Garidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Bechtold-Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-3809","authenticated-orcid":false,"given":"Pierre","family":"Guibal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Steinmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4563-8238","authenticated-orcid":false,"given":"Cyrille","family":"Chery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Peuker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan E","family":"Mould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shousong Jason","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8303-6564","authenticated-orcid":false,"given":"Charlie","family":"Bupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3808-3158","authenticated-orcid":false,"given":"Felix","family":"Wiggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogita","family":"Krishnamachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5673-6427","authenticated-orcid":false,"given":"Indira","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4023-5969","authenticated-orcid":false,"given":"Stefan","family":"Bleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2026.104169_bib0001","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.xphs.2022.02.009","article-title":"Industry perspective on the use and characterization of polysorbates for biopharmaceutical products part 1: survey report on current State and common practices for handling and control of polysorbates","volume":"111","author":"Wuchner","year":"2022","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2026.104169_bib0002","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.xphs.2022.08.021","article-title":"Industry perspective on the use and characterization of polysorbates for biopharmaceutical products part 2: survey report on control strategy preparing for the future","volume":"111","author":"Wuchner","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0003","article-title":"Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives","volume":"12","author":"Felix","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.xphs.2026.104169_bib0004","article-title":"Oxidation of polysorbates - an underestimated degradation pathway?","volume":"6","author":"Weber","year":"2023","journal-title":"Int J Pharm X"},{"issue":"12","key":"10.1016\/j.xphs.2026.104169_bib0005","first-page":"14","article-title":"Alternative excipients for protein stabilization in protein therapeutics: overcoming the limitations of polysorbates","author":"Casta\u00f1eda Ruiz","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104169_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121706","article-title":"Poloxamer 188 as surfactant in biological formulations - an alternative for polysorbate 20\/80?","volume":"620","author":"Bollenbach","year":"2022","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2026.104169_bib0007","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.xphs.2021.12.002","article-title":"Emerging challenges and innovations in surfactant-mediated stabilization of biologic formulations","volume":"111","author":"Katz","year":"2022","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104169_bib0008","first-page":"42","article-title":"The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation","volume":"5","author":"Li","year":"2022","journal-title":"Antib Ther"},{"issue":"4","key":"10.1016\/j.xphs.2026.104169_bib0009","first-page":"22","article-title":"Current challenges and control strategies for polysorbates in biopharmaceuticals","volume":"60","author":"Mathaes","year":"2024","journal-title":"PDA Letter"},{"issue":"8","key":"10.1016\/j.xphs.2026.104169_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11095-018-2430-5","article-title":"Considerations for the use of polysorbates in biopharmaceuticals","volume":"35","author":"Jones","year":"2018","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2026.104169_bib0011","first-page":"6","article-title":"Autoxidation of polysorbates","volume":"67","author":"Donbrowx","year":"1978","journal-title":"J Pharmaceut Sclences"},{"key":"10.1016\/j.xphs.2026.104169_bib0012","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-812503-8.00006-3","article-title":"Oxidative degradation of surfactants: mechanisms","author":"Sch\u00f6neich","year":"2023","journal-title":"Surfact Biopharmaceut Develop"},{"issue":"10","key":"10.1016\/j.xphs.2026.104169_bib0013","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1016\/j.xphs.2020.06.028","article-title":"Micelle driven oxidation mechansim and novel oxidation markers for different grades of polysorbate 20 and 80","volume":"109","author":"Kranz","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2022.06.011","article-title":"Intra-micellar and extra-micellar oxidation in phosphate and histidine buffers containing polysorbate 80","author":"Peters","year":"2022","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104169_bib0015","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/acs.molpharmaceut.4c00461","article-title":"Coarse-grained molecular dynamics simulation of heterogeneous polysorbate 80 surfactants and their interactions with small molecules and proteins","volume":"21","author":"Lou","year":"2024","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104169_bib0016","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1021\/acs.molpharmaceut.4c01015","article-title":"Micellar solvent accessibility of esterified polyoxyethylene chains as crucial element of polysorbate oxidation: a density functional theory, molecular dynamics simulation and liquid chromatography\/mass spectrometry investigation","volume":"22","author":"Weber","year":"2025","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2026.104169_bib0017","first-page":"15","article-title":"Comparative stability study of polysorbate 20 and polysorbate 80 related to oxidative degradation","author":"Kozuch","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0018","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.xphs.2024.10.038","article-title":"Impact of citrate on mitigating iron mediated polysorbate 80 degradation in biotherapeutic formulation placebos","volume":"114","author":"Yang","year":"2025","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114763","article-title":"Mechanisms of polysorbate 80 oxidation: acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids","author":"Wu","year":"2025","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1016\/j.xphs.2026.104169_bib0020","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1021\/acs.molpharmaceut.5c00034","article-title":"Reduced IgG1 antibody left-twisted antiparallel beta-sheet structure stability occurs under metal-catalyzed oxidation conditions in the presence of polysorbates","volume":"22","author":"Lehtimaki","year":"2025","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0021","first-page":"17","article-title":"Determining the oxidation mechanism through radical intermediates in polysorbates 80 and 20 by electron paramagnetic resonance spectroscopy","author":"Sutton","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.xphs.2026.104169_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2022.01.026","article-title":"Near UV and visible light photo-degradation mechanisms in citrate buffer: one-electron reduction of peptide and protein disulfides promotes oxidation and cis\/trans isomerization of unsaturated fatty acids of polysorbate 80","author":"Prajapati","year":"2022","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0023","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.xphs.2024.10.053","article-title":"Mechanistic characterization of iron-catalyzed oxidation of polysorbate 80: the role of ferrous iron, hydrogen peroxide, and superoxide","volume":"114","author":"Richards","year":"2025","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0024","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.xphs.2025.01.003","article-title":"The role of histidine buffer in the iron-catalyzed formation of oxidizing species in pharmaceutical formulations: mechanistic studies","volume":"114","author":"Zhang","year":"2025","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104169_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103799","article-title":"Metal-induced oxidation of polysorbate 80 in the presence of hydrogen peroxide: mechanistic studies","volume":"114","author":"Wu","year":"2025","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104169_bib0026","first-page":"13","article-title":"Primary processes of free radical formation in pharmaceutical formulations of therapeutic proteins","author":"Schoneich","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.xphs.2026.104169_bib0027","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.xphs.2022.10.012","article-title":"Extensive characterization of polysorbate 80 oxidative degradation under stainless steel conditions","volume":"112","author":"Zheng","year":"2023","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2026.104169_bib0028","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.xphs.2019.01.006","article-title":"Factors influencing polysorbate\u2019s sensitivity against enzymatic hydrolysis and oxidative degradation","volume":"108","author":"Kranz","year":"2019","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104169_bib0029","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.xphs.2020.06.030","article-title":"Evaluation of super refined polysorbate 20 with respect to polysorbate degradation, particle formation and protein stability","volume":"109","author":"Doshi","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114521","article-title":"Comparative analysis and mechanistic insights into polysorbate 80 stability differences in biopharmaceutical buffer systems","volume":"205","author":"Cheng","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2026.104169_bib0031","first-page":"101","article-title":"Comprehensive investigation of factors influencing the degradation of polysorbate 20: insights into mechanisms and interactions using a design of experiments approach","author":"Schultz-Fademrecht","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2026.104169_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121496","article-title":"Mechanistic understanding of metal-catalyzed oxidation of polysorbate 80 and monoclonal antibody in biotherapeutic formulations","volume":"615","author":"Bensaid","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104169_bib0033","article-title":"A comprehensive review on the stability and degradation of polysorbates in biopharmaceuticals","author":"Morker","year":"2025","journal-title":"Ejpps Eur J Parenteral Pharmaceut Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0034","article-title":"Characterization of radicals in polysorbate 80 using electron paramagnetic resonance (EPR) spectroscopy and spin trapping","volume":"4","author":"Mittag","year":"2022","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.xphs.2026.104169_bib0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jcis.2022.02.092","article-title":"Reactive oxygen species (ROS) in colloidal systems: are \"PEG-free\" surfactants the answer?","volume":"616","author":"David Friedl","year":"2022","journal-title":"J Colloid Interface Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104169_bib0036","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jps.24314","article-title":"Oxidative degradation of polysorbate surfactants studied by liquid chromatography\u2013mass spectrometry","volume":"104","author":"Borisov","year":"2015","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0037","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jps.22290","article-title":"Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis","volume":"100","author":"Kishore","year":"2011","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104169_bib0038","doi-asserted-by":"crossref","first-page":"e9715","DOI":"10.1002\/rcm.9715","article-title":"Detailed profiling of polysorbate 80 oxidative degradation products and hydrolysates using liquid chromatography-tandem mass spectrometry analysis","volume":"38","author":"Konya","year":"2024","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.xphs.2026.104169_bib0039","doi-asserted-by":"crossref","first-page":"12","DOI":"10.56530\/lcgc.int.nj3790f3","article-title":"Polysorbate analysis in biopharmaceutical applications \u2014 a snapshot of the analytical toolbox","author":"Alvarez","year":"2025","journal-title":"LCGC Int"},{"issue":"7","key":"10.1016\/j.xphs.2026.104169_bib0040","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.xphs.2017.03.001","article-title":"Trends on analytical characterization of polysorbates and their degradation products in biopharmaceutical formulations","volume":"106","author":"Martos","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123955","article-title":"All-in-one stability indicating polysorbate 20 degradation root-cause analytics via UPLC-QDa","volume":"1232","author":"Carle","year":"2024","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0042","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejpb.2023.11.024","article-title":"Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations","volume":"194","author":"Gregoritza","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104169_bib0043","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2375798","article-title":"Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations","volume":"16","author":"Maier","year":"2024","journal-title":"MAbs"},{"key":"10.1016\/j.xphs.2026.104169_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2023.01.003","article-title":"Characterization of recombinantly-expressed hydrolytic enzymes from Chinese hamster ovary cells: identification of host cell proteins that degrade polysorbate","author":"Kovner","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejpb.2023.04.021","article-title":"A fast and sensitive high-throughput assay to assess polysorbate-degrading hydrolytic activity in biopharmaceuticals","volume":"187","author":"Gupta","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104169_bib0046","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11095-021-03160-3","article-title":"Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases","volume":"39","author":"Zhang","year":"2022","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2026.104169_bib0047","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.xphs.2021.06.033","article-title":"Identification and characterization of polysorbate-degrading enzymes in a monoclonal antibody formulation","volume":"110","author":"Graf","year":"2021","journal-title":"J Pharm Sci"},{"issue":"24","key":"10.1016\/j.xphs.2026.104169_bib0048","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1021\/acs.analchem.2c00059","article-title":"Activity-based protein profiling probe for the detection of enzymes catalyzing polysorbate degradation","volume":"94","author":"Liu","year":"2022","journal-title":"Anal Chem"},{"key":"10.1016\/j.xphs.2026.104169_bib0049","article-title":"Investigating pH effects on enzymes catalyzing polysorbate degradation by activity-based protein profiling","author":"Dehghani","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0050","article-title":"Without a trace: multiple knockout of CHO host cell hydrolases to prevent polysorbate degradation in biologics","author":"Weiss","year":"2025","journal-title":"Trends Biotechnol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104169_bib0051","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/bit.26237","article-title":"Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations","volume":"114","author":"Chiu","year":"2017","journal-title":"Biotechnol Bioeng"},{"issue":"7","key":"10.1016\/j.xphs.2026.104169_bib0052","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1021\/acschembio.5c00081","article-title":"Discovery of chemical tools for polysorbate-degradative enzyme control in the biopharmaceutical upstream process via multi-omic profiling of host cell clones","volume":"20","author":"Tsukidate","year":"2025","journal-title":"ACS Chem Biol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104169_bib0053","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2135183","article-title":"Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms","volume":"14","author":"Hecht","year":"2022","journal-title":"MAbs"},{"issue":"7","key":"10.1016\/j.xphs.2026.104169_bib0054","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.21474\/IJAR01\/952","article-title":"Joyeeta;Bhaishya, Debabrat Chemical and biological properties of lauric acid: a review","volume":"4","author":"Sandhya","year":"2016","journal-title":"Int J Adv Res"},{"issue":"12","key":"10.1016\/j.xphs.2026.104169_bib0055","first-page":"69","article-title":"Densities of vegetable oils and fatty acids","author":"Noureddini","year":"1992","journal-title":"JAOCS"},{"issue":"8","key":"10.1016\/j.xphs.2026.104169_bib0056","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/jps.22123","article-title":"Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation","volume":"99","author":"Wuchner","year":"2010","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2026.104169_bib0057","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.xphs.2021.05.012","article-title":"Polysorbate degradation and particle formation in a high concentration mAb: formulation strategies to minimize effect of enzymatic Polysorbate degradation","volume":"110","author":"Roy","year":"2021","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104169_bib0058","doi-asserted-by":"crossref","DOI":"10.1186\/s41120-022-00064-3","article-title":"Formulation mitigations for particle formation induced by enzymatic hydrolysis of polysorbate 20 in protein-based drug products: insights from a full-factorial longitudinal study","volume":"8","author":"Yuk","year":"2022","journal-title":"AAPS Open"},{"issue":"9","key":"10.1016\/j.xphs.2026.104169_bib0059","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1016\/j.xphs.2024.07.010","article-title":"A comparison of polysorbates and alternative surfactants for interfacial stress protection and mitigation of fatty acid particle formation in the presence of an esterase","volume":"113","author":"Roy","year":"2024","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104169_bib0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.xphs.2021.10.008","article-title":"Fatty acids can induce the formation of proteinaceous particles in monoclonal antibody formulations","volume":"111","author":"Zhang","year":"2022","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2026.104169_bib0061","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1021\/acs.molpharmaceut.4c00754","article-title":"Mitigation strategies against antibody aggregation induced by oleic acid in liquid formulations","volume":"21","author":"Zurcher","year":"2024","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104169_bib0062","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.xphs.2019.10.069","article-title":"Comparison of polysorbate 80 hydrolysis and oxidation on the aggregation of a monoclonal antibody","volume":"109","author":"Larson","year":"2020","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0063","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.xphs.2022.10.009","article-title":"Surface-induced protein aggregation and particle formation in biologics: current understanding of mechanisms, detection and mitigation strategies","volume":"112","author":"Kopp","year":"2023","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104169_bib0064","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.xphs.2019.10.015","article-title":"What makes polysorbate functional? Impact of polysorbate 80 grade and quality on IgG stability during mechanical stress","volume":"109","author":"Grabarek","year":"2020","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2026.104169_bib0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11095-022-03217-x","article-title":"A mechanistic understanding of monoclonal antibody interfacial protection by hydrolytically degraded polysorbate 20 and 80 under IV bag conditions","volume":"39","author":"Kannan","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104169_bib0066","first-page":"111","article-title":"Fatty acid solubility determination in biopharmaceutical formulations containing polysorbate 20 using a design of experiments approach","author":"Gro\u00df","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0067","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.xphs.2020.10.004","article-title":"Dissolution of polysorbate 20 degradation related free fatty acid particles in intravenous bag solutions","volume":"110","author":"Doshi","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105242","article-title":"Setting impurity limits for endogenous substances: recommendations for a harmonized procedure and an example using fatty acids","volume":"134","author":"Jolly","year":"2022","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104169_bib0069","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/NAN.0000000000000194","article-title":"Review of intravenous lipid emulsion therapy","volume":"39","author":"Spray","year":"2016","journal-title":"J Infus Nurs"},{"issue":"4","key":"10.1016\/j.xphs.2026.104169_bib0070","first-page":"308","article-title":"Intravenous lipid emulsions in the critically ill: an update","volume":"22","author":"Manzanares","year":"2016","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0071","first-page":"104","article-title":"Parenteral lipid emulsions: the state of the art","volume":"28","author":"Da Prat","year":"2025","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"10.1016\/j.xphs.2026.104169_bib0072","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jpen.1537","article-title":"Essential fatty acid requirements and intravenous lipid emulsions","volume":"43","author":"Gramlich","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"10.1016\/j.xphs.2026.104169_bib0073","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1208\/s12248-012-9367-0","article-title":"Mechanistic determinants of biotherapeutics absorption following SC administration","volume":"14","author":"Richter","year":"2012","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0074","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ab.2003.09.038","article-title":"Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"324","author":"Baker","year":"2004","journal-title":"Anal Biochem"},{"issue":"10","key":"10.1016\/j.xphs.2026.104169_bib0075","first-page":"2918","article-title":"Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice","volume":"5","author":"van Tellingen","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0076","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1570-0232(02)00167-8","article-title":"Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometry","volume":"773","author":"Sparreboom","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107208","article-title":"In vivo metabolic pathways and tissue distribution of pharmaceutical excipient polysorbate 80 using ultra-high performance liquid chromatography-high resolution mass spectrometry analysis","volume":"212","author":"Wang","year":"2025","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104169_bib0078","article-title":"Immunogenicity of protein pharmaceuticals","author":"Dingman","year":"2018","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2026.104169_bib0079","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41573-024-01051-x","article-title":"Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics","volume":"23","author":"Carter","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.xphs.2026.104169_bib0080","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.xphs.2022.05.005","article-title":"Investigation of immune responses to oxidation, deamidation, and isomerization in therapeutic antibodies using preclinical immunogenicity risk assessment assays","volume":"111","author":"Zeunik","year":"2022","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2026.104169_bib0081","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.xphs.2018.06.029","article-title":"Submicron size particles of a murine monoclonal antibody are more immunogenic than soluble oligomers or micron size particles upon subcutaneous administration in mice","volume":"107","author":"Kijanka","year":"2018","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2026.104169_bib0082","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nbt1303","article-title":"A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs","volume":"25","author":"Shankar","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104169_bib0083","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yrtph.2009.03.012","article-title":"Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies","volume":"54","author":"Ponce","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104169_bib0084","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11095-024-03678-2","article-title":"A high threshold of biotherapeutic aggregate numbers is needed to induce an immunogenic response In vitro, In vivo, and in the clinic","volume":"41","author":"Cohen","year":"2024","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104169_bib0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.xphs.2026.104169_bib0086","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"10.1016\/j.xphs.2026.104169_bib0087","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant System AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.xphs.2026.104169_bib0088","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.xphs.2026.104169_bib0089","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/jps.21523","article-title":"Vaccine adjuvants: current challenges and future approaches","volume":"98","author":"Wilson-Welder","year":"2009","journal-title":"J Pharm Sci"},{"issue":"27","key":"10.1016\/j.xphs.2026.104169_bib0090","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1073\/pnas.1107941108","article-title":"Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88","volume":"108","author":"Seubert","year":"2011","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:32:49Z","timestamp":1772721169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022354926000183"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104169","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do we worry too much about polysorbate degradation? An industry-wide perspective with real-life case studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104169"}}